Submit to IJMS Review for IJMS Propose a Special Issue

Journal Menu

Journal Browser

Oxidative Stress and Antioxidants in Human Diseases

Print Special Issue Flyer
Special Issue Editors
Special Issue Information
Keywords
Published Papers

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (28 April 2024) | Viewed by 17732

Share This Special Issue

Special Issue Editor

Prof. Dr. Lyubov Iljinichna Kolesnikova

E-Mail Website
Guest Editor

Scientific Сentre for Family Health and Human Reproduction Problems, 664003 Irkutsk, Russia
Interests: oxidative stress; metabolic stress; diseases; aging; antioxidants; free radical pathology; reactive oxygen species; cellular damage; antioxidant therapy

Special Issue Information

Dear Colleagues,

Since the middle of the 20th century, there has been significant progress in research on free radical biology and medicine, and accordingly, the list of diseases associated with free radicals has expanded significantly. Currently, the problem of the molecular and cellular mechanisms of oxidative stress development is extremely relevant for medical science. It was proved that excess accumulation of oxidative stress products changes proteins, fat, carbohydrates, nucleic acids, water, and electrolyte metabolism, which can cause severe tissue damages and organism adaptive capacity reduction. It can play an important role in the pathogenesis of a significant number of pathologies (obesity, diabetes mellitus, cardiovascular diseases, reproductive disorders, COVID-19, etc.), and there are also several data about the possible role of oxidative stress in the aging process. While there are widely used markers of oxidative stress, new data are emerging on other potential biomarkers for free radical damage to cells. To date, however, there is no single view on the mechanisms of free radical reactions and the antioxidant defense system regulation.

Because of that, this issue of the International Journal of Molecular Sciences will focus on new insights into the role of oxidative stress and antioxidants in the pathogenesis of human diseases.

Prof. Dr. Lyubov Iljinichna Kolesnikova
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

oxidative stress
metabolic stress
diseases
aging
antioxidants
free radical pathology
reactive oxygen species
cellular damage
antioxidant therapy

Published Papers (12 papers)

Download All Papers

Research

Jump to: Review

14 pages, 2133 KiB

Open AccessArticle

The Potential of Twendee X^® as a Safe Antioxidant Treatment for Systemic Sclerosis

by Fukka You, Carole Nicco, Yoshiaki Harakawa, Toshikazu Yoshikawa and Haruhiko Inufusa

Int. J. Mol. Sci. 2024, 25(5), 3064; https://doi.org/10.3390/ijms25053064 - 06 Mar 2024

Viewed by 872

Abstract

Systemic sclerosis (SSc) is an autoimmune disease characterized by systemic skin hardening, which combines Raynaud’s phenomenon and other vascular disorders, skin and internal organ fibrosis, immune disorders, and a variety of other abnormalities. Symptoms vary widely among individuals, and personalized treatment is sought for each patient. Since there is no fundamental cure for SSc, it is designated as an intractable disease with patients receiving government subsidies for medical expenses in Japan. Oxidative stress (OS) has been reported to play an important role in the cause and symptoms of SSc. HOCl-induced SSc mouse models are known to exhibit skin and visceral fibrosis, vascular damage, and autoimmune-like symptoms observed in human SSc. The antioxidant combination Twendee X^® (TwX) is a dietary supplement consisting of vitamins, amino acids, and CoQ10. TwX has been proven to prevent dementia in humans with mild cognitive impairment and significantly improve cognitive impairment in an Alzheimer’s disease mouse model by regulating OS through a strong antioxidant capacity that cannot be achieved with a single antioxidant ingredient. We evaluated the effectiveness of TwX on various symptoms of HOCl-induced SSc mice. TwX-treated HOCl-induced SSc mice showed significantly reduced lung and skin fibrosis compared to untreated HOCl-induced SSc mice. TwX also significantly reduced highly oxidized protein products (AOPP) in serum and suppressed Col-1 gene expression and activation of B cells involved in autoimmunity. These findings suggest that TwX has the potential to be a new antioxidant treatment for SSc without side effects. Full article

(This article belongs to the Special Issue Oxidative Stress and Antioxidants in Human Diseases)

► Show Figures

Figure 1

14 pages, 4383 KiB

Open AccessArticle

Hepatoprotective and Antioxidant Effects of Nanopiperine against Cypermethrin via Mitigation of Oxidative Stress, Inflammations and Gene Expression Using qRT-PCR

by Sohail Hussain, Abdulmajeed M. Jali, Saeed Alshahrani, Khairat H. M. Khairat, Rahimullah Siddiqui, Mohammad Intakhab Alam, Raisuddin Ali, Manal Mohammed, Andleeb Khan, Hamad Al Shahi, Ali Hanbashi, Marwa Qadri and Mohammad Ashafaq

Int. J. Mol. Sci. 2023, 24(20), 15361; https://doi.org/10.3390/ijms242015361 - 19 Oct 2023

Cited by 2 | Viewed by 1122

Abstract

Cypermethrin (Cyp) is a pyrethroid that has been associated with the toxicity of various organs. The aim of our study was to evaluate the hepatoprotective and antioxidant activities of nano-piperine (NP) against Cyp toxicity. Cyp (50 mg/kg) was administered orally in all animals of groups III–VI for 15 days. Groups IV–VI each received three doses of NP (125, 250, and 500 µg/kg/day) for 10 days after receiving the Cyp dosage, which was given after 1 h. A rise in serum biomarkers (ALT, AST, ALP, total protein, and albumin), which are indicators of toxicity alongside anomalous oxidative stress indices (lipid peroxidation (LPO), glutathione (GSH), superoxide dismutase (SOD) and catalase), was detected. After Cyp treatment, we observed upregulated cytokines, caspase expression, and histological analysis that the showed distortion of cell shape. However, the administration of NP dramatically reversed all of the Cyp-induced alterations, inducing reductions in serum marker levels, stress level, the production of cytokines, and caspase expression. Additionally, all of the histopathological alterations were minimized to values that were comparable to normal levels. The present findings suggested that NP exhibits potent antioxidant and anti-inflammatory activities that can protect rats’ livers against Cyp-induced liver damage through hepatoprotective activities. Full article

(This article belongs to the Special Issue Oxidative Stress and Antioxidants in Human Diseases)

► Show Figures

Graphical abstract

14 pages, 1848 KiB

Open AccessArticle

Serum Total Antioxidant Capacity (TAC) and TAC/Lymphocyte Ratio as Promising Predictive Markers in COVID-19

by Zoltán Horváth-Szalai, Rita Jakabfi-Csepregi, Balázs Szirmay, Dániel Ragán, Gerda Simon, Zoltán Kovács-Ábrahám, Péter Szabó, Dávid Sipos, Ágnes Péterfalvi, Attila Miseta, Csaba Csontos, Tamás Kőszegi and Ildikó Tóth

Int. J. Mol. Sci. 2023, 24(16), 12935; https://doi.org/10.3390/ijms241612935 - 18 Aug 2023

Cited by 1 | Viewed by 948

Abstract

SARS-CoV-2 infection might cause a critical disease, and patients’ follow-up is based on multiple parameters. Oxidative stress is one of the key factors in the pathogenesis of COVID-19 suggesting that its level could be a prognostic marker. Therefore, we elucidated the predictive value of the serum non-enzymatic total antioxidant capacity (TAC) and that of the newly introduced TAC/lymphocyte ratio in COVID-19. We included 61 COVID-19 (n = 27 ward, n = 34 intensive care unit, ICU) patients and 29 controls in our study. Serum TAC on admission was measured by an enhanced chemiluminescence (ECL) microplate assay previously validated by our research group. TAC levels were higher (p < 0.01) in ICU (median: 407.88 µmol/L) than in ward patients (315.44 µmol/L) and controls (296.60 µmol/L). Besides the classical parameters, both the TAC/lymphocyte ratio and TAC had significant predictive values regarding the severity (AUC-ROC for the TAC/lymphocyte ratio: 0.811; for TAC: 0.728) and acute kidney injury (AUC-ROC for the TAC/lymphocyte ratio: 0.747; for TAC: 0.733) in COVID-19. Moreover, the TAC/lymphocyte ratio had significant predictive value regarding mortality (AUC-ROC: 0.752). Serum TAC and the TAC/lymphocyte ratio might offer valuable information regarding the severity of COVID-19. TAC measured by our ECL microplate assay serves as a promising marker for the prediction of systemic inflammatory diseases. Full article

(This article belongs to the Special Issue Oxidative Stress and Antioxidants in Human Diseases)

► Show Figures

Figure 1

16 pages, 4315 KiB

Open AccessArticle

Synergistic Effects of Vitis vinifera L. and Centella asiatica against CCl₄-Induced Liver Injury in Mice

by Suvesh Munakarmi, Yamuna Gurau, Juna Shrestha, Prabodh Risal, Ho Sung Park, Geum-Hwa Lee and Yeon Jun Jeong

Int. J. Mol. Sci. 2023, 24(14), 11255; https://doi.org/10.3390/ijms241411255 - 09 Jul 2023

Viewed by 1754

Abstract

Liver injury can be acute or chronic, resulting from a variety of factors, including viral hepatitis, drug overdose, idiosyncratic drug reaction, or toxins, while the progression of pathogenesis in the liver rises due to the involvement of numerous cytokines and growth factor mediators. Thus, the identification of more effective biomarker-based active phytochemicals isolated from medicinal plants is a promising strategy to protect against CCl₄-induced liver injury. Vitis vinifera L. (VE) and Centella asiatica (CE) are well-known medicinal plants that possess anti-inflammatory and antioxidant properties. However, synergism between the two has not previously been studied. Here, we investigated the synergistic effects of a V. vinifera L. (VE) leaf, C. asiatica (CE) extract combination (VCEC) against CCl₄-induced liver injury. Acute liver injury was induced by a single intraperitoneal administration of CCl₄ (1 mL/kg). VCEC was administered orally for three consecutive days at various concentrations (100 and 200 mg/kg) prior to CCl₄ injection. The extent of liver injury and the protective effects of VCEC were evaluated by biochemical analysis and histopathological studies. Oxidative stress was evaluated by measuring malondialdehyde (MDA) and glutathione (GSH) levels and Western blotting. VCEC treatment significantly reduced serum transaminase levels (AST and ALT), tumor necrosis factor-α (TNF-α), and reactive oxygen species (ROS). CCl₄- induced apoptosis was inhibited by VCEC treatment by reducing cleaved caspase-3 and Bcl2-associated X protein (Bax). VCEC-treated mice significantly restored cytochrome P450 2E1, nuclear factor erythroid 2-related factor 2 (Nrf2), and heme oxygenase-1 (HO-1) expression in CCl4-treated mice. In addition, VCEC downregulated overexpression of proinflammatory cytokines and hepatic nuclear factor kappa B (NF-κB) and inhibited CCl4-mediated apoptosis. Collectively, VCEC exhibited synergistic protective effects against liver injury through its antioxidant, anti-inflammatory, and antiapoptotic ability against oxidative stress, inflammation, and apoptosis. Therefore, VCEC appears promising as a potential therapeutic agent for CCl₄-induced acute liver injury in mice. Full article

(This article belongs to the Special Issue Oxidative Stress and Antioxidants in Human Diseases)

► Show Figures

Figure 1

13 pages, 4002 KiB

Open AccessArticle

Thymoquinone Ameliorates Carfilzomib-Induced Renal Impairment by Modulating Oxidative Stress Markers, Inflammatory/Apoptotic Mediators, and Augmenting Nrf2 in Rats

by Marwa M. Qadri, Mohammad Firoz Alam, Zenat A. Khired, Reem O. Alaqi, Amani A. Khardali, Moudi M. Alasmari, Ahmad S. S. Alrashah, Hisham M. A. Muzafar and Abdullah M. Qahl

Int. J. Mol. Sci. 2023, 24(13), 10621; https://doi.org/10.3390/ijms241310621 - 25 Jun 2023

Cited by 2 | Viewed by 1387

Abstract

Chemotherapy-induced kidney damage is an emerging problem that restricts cancer treatment effectiveness. The proteasome inhibitor carfilzomib (CFZ) is primarily used to treat multiple myeloma and has been associated with severe renal injury in humans. CFZ-induced nephrotoxicity remains an unmet medical need, and there is an urgent need to find and develop a nephroprotective and antioxidant therapy for this condition. Thymoquinone (TQ) is a bioactive compound that has been isolated from Nigella sativa seeds. It has a wide range of pharmacological properties. Therefore, this experimental design aimed to study the effectiveness of TQ against CFZ-induced renal toxicity in rats. The first group of rats was a normal control (CNT); the second group received CFZ (4 mg/kg b.w.); the third and fourth groups received TQ (10 and 20 mg/kg b.w.) 2 h before receiving CFZ; the fifth group received only TQ (20 mg/kg b.w.). This experiment was conducted for 16 days, and at the end of the experiment, blood samples and kidney tissue were collected for biochemical assays. The results indicated that administration of CFZ significantly enhanced serum marker levels such as BUN, creatinine, and uric acid in the CFZ group. Similarly, it was also noticed that CFZ administration induced oxidative stress by reducing antioxidants (GSH) and antioxidant enzymes (CAT and SOD) and increasing lipid peroxidation. CFZ treatment also enhanced the expression of IL-1β, IL-6, and TNF-α production. Moreover, CFZ increased caspase-3 concentrations and reduced Nrf2 expression in the CFZ-administered group. However, treatment with 10 and 20 mg/kg TQ significantly decreased serum markers and increased antioxidant enzymes. TQ treatment considerably reduced IL-1β, IL-6, TNF-α, and caspase-3 concentrations. Overall, this biochemical estimation was also supported by histopathological outcomes. This study revealed that TQ administration significantly mitigated the negative effects of CFZ treatment on Nrf2 expression. Thus, it indicates that TQ may have utility as a potential drug to prevent CFZ-induced nephrotoxicity in the future. Full article

(This article belongs to the Special Issue Oxidative Stress and Antioxidants in Human Diseases)

► Show Figures

Figure 1

15 pages, 2861 KiB

Open AccessArticle

Generation and Characterization of CYP2E1-Overexpressing HepG2 Cells to Study the Role of CYP2E1 in Hepatic Hypoxia-Reoxygenation Injury

by Nouf Alwadei, Mamunur Rashid, Devaraj Venkatapura Chandrashekar, Simin Rahighi, Jennifer Totonchy, Ajay Sharma and Reza Mehvar

Int. J. Mol. Sci. 2023, 24(9), 8121; https://doi.org/10.3390/ijms24098121 - 01 May 2023

Cited by 1 | Viewed by 2045

Abstract

The mechanisms of hepatic ischemia/reperfusion (I/R) injury, which occurs during liver transplantation or surgery, are poorly understood. The purpose of the current study was to generate and characterize a HepG2 cell line with a stable overexpression of CYP2E1 to investigate the role of the enzyme in hypoxia/reperfusion (H/R) injury in an ex vivo setting. GFP-tagged CYP2E1 and control clones were developed, and their gene expression and protein levels of GFP and CYP2E1 were determined using RT-PCR and ELISA/Western blot analysis, respectively. Additionally, the CYP2E1 catalytic activity was determined by UPLC-MS/MS analysis of 6-hydroxychlorzoxazone formed from the chlorzoxazone substrate. The CYP2E1 and control clones were subjected to hypoxia (10 h) and reoxygenation (0.5 h), and cell death and reactive oxygen species (ROS) generation were quantitated using LDH and flow cytometry, respectively. Compared with the control clone, the selected CYP2E1 clone showed a 720-fold increase in CYP2E1 expression and a prominent band in the western blot analysis, which was associated with a 150-fold increase in CYP2E1 catalytic activity. The CYP2E1 clone produced 2.3-fold more ROS and 1.9-fold more cell death in the H/R model. It is concluded that the constitutive CYP2E1 in the liver may play a detrimental role in hepatic I/R injury. Full article

(This article belongs to the Special Issue Oxidative Stress and Antioxidants in Human Diseases)

► Show Figures

Figure 1

Review

Jump to: Research

17 pages, 682 KiB

Open AccessReview

Role of Oxidative Stress in Sensorineural Hearing Loss

by Masato Teraoka, Naohito Hato, Haruhiko Inufusa and Fukka You

Int. J. Mol. Sci. 2024, 25(8), 4146; https://doi.org/10.3390/ijms25084146 - 09 Apr 2024

Viewed by 580

Abstract

Hearing is essential for communication, and its loss can cause a serious disruption to one’s social life. Hearing loss is also recognized as a major risk factor for dementia; therefore, addressing hearing loss is a pressing global issue. Sensorineural hearing loss, the predominant type of hearing loss, is mainly due to damage to the inner ear along with a variety of pathologies including ischemia, noise, trauma, aging, and ototoxic drugs. In addition to genetic factors, oxidative stress has been identified as a common mechanism underlying several cochlear pathologies. The cochlea, which plays a major role in auditory function, requires high-energy metabolism and is, therefore, highly susceptible to oxidative stress, particularly in the mitochondria. Based on these pathological findings, the potential of antioxidants for the treatment of hearing loss has been demonstrated in several animal studies. However, results from human studies are insufficient, and future clinical trials are required. This review discusses the relationship between sensorineural hearing loss and reactive oxidative species (ROS), with particular emphasis on age-related hearing loss, noise-induced hearing loss, and ischemia–reperfusion injury. Based on these mechanisms, the current status and future perspectives of ROS-targeted therapy for sensorineural hearing loss are described. Full article

(This article belongs to the Special Issue Oxidative Stress and Antioxidants in Human Diseases)

► Show Figures

Figure 1

16 pages, 338 KiB

Open AccessReview

Insights into the Management of Chronic Hepatitis in Children—From Oxidative Stress to Antioxidant Therapy

by Ileana Ioniuc, Ancuta Lupu, Irina Tarnita, Alexandra Mastaleru, Laura Mihaela Trandafir, Vasile Valeriu Lupu, Iuliana Magdalena Starcea, Mirabela Alecsa, Ionela Daniela Morariu, Delia Lidia Salaru and Alice Azoicai

Int. J. Mol. Sci. 2024, 25(7), 3908; https://doi.org/10.3390/ijms25073908 - 31 Mar 2024

Viewed by 547

Abstract

Recent research has generated awareness of the existence of various pathophysiological pathways that contribute to the development of chronic diseases; thus, pro-oxidative factors have been accepted as significant contributors to the emergence of a wide range of diseases, from inflammatory to malignant. Redox homeostasis is especially crucial in liver pathology, as disturbances at this level have been linked to a variety of chronic diseases. Hepatitis is an umbrella term used to describe liver inflammation, which is the foundation of this disease regardless of its cause. Chronic hepatitis produces both oxidative stress generated by hepatocyte inflammation and viral inoculation. The majority of hepatitis in children is caused by a virus, and current studies reveal that 60–80% of cases become chronic, with many young patients still at risk of advancing liver damage. This review intends to emphasize the relevance of understanding these pathological redox pathways, as well as the need to update therapeutic strategies in chronic liver pathology, considering the beneficial effects of antioxidants. Full article

(This article belongs to the Special Issue Oxidative Stress and Antioxidants in Human Diseases)

17 pages, 688 KiB

Open AccessReview

Bioactive Compounds for Combating Oxidative Stress in Dermatology

by Delia Turcov, Anca Zbranca-Toporas and Daniela Suteu

Int. J. Mol. Sci. 2023, 24(24), 17517; https://doi.org/10.3390/ijms242417517 - 15 Dec 2023

Cited by 1 | Viewed by 984

Abstract

There are extensive studies that confirm the harmful and strong influence of oxidative stress on the skin. The body’s response to oxidative stress can vary depending on the type of reactive oxygen species (ROS) or reactive nitrogen species (RNS) and their metabolites, the duration of exposure to oxidative stress and the antioxidant capacity at each tissue level. Numerous skin diseases and pathologies are associated with the excessive production and accumulation of free radicals. title altered Both categories have advantages and disadvantages in terms of skin structures, tolerability, therapeutic performance, ease of application or formulation and economic efficiency. The effect of long-term treatment with antioxidants is evaluated through studies investigating their protective effect and the improvement of some phenomena caused by oxidative stress. This article summarizes the available information on the presence of compounds used in dermatology to combat oxidative stress in the skin. It aims to provide an overview of all the considerations for choosing an antioxidant agent, the topics for further research and the answers sought in order to optimize therapeutic performance. Full article

(This article belongs to the Special Issue Oxidative Stress and Antioxidants in Human Diseases)

► Show Figures

Figure 1

27 pages, 3569 KiB

Open AccessReview

The Role of the Oxidative State and Innate Immunity Mediated by TLR7 and TLR9 in Lupus Nephritis

by Raquel Echavarria, Ernesto Germán Cardona-Muñoz, Pablo Ortiz-Lazareno, Jorge Andrade-Sierra, Luis Francisco Gómez-Hermosillo, Jorge Casillas-Moreno, Tannia Isabel Campos-Bayardo, Daniel Román-Rojas, Andrés García-Sánchez and Alejandra Guillermina Miranda-Díaz

Int. J. Mol. Sci. 2023, 24(20), 15234; https://doi.org/10.3390/ijms242015234 - 16 Oct 2023

Viewed by 2652

Abstract

Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE) and is considered one of the leading causes of mortality. Multiple immunological pathways are involved in the pathogenesis of SLE, which makes it imperative to deepen our knowledge about this disease’s immune-pathological complexity and explore new therapeutic targets. Since an altered redox state contributes to immune system dysregulation, this document briefly addresses the roles of oxidative stress (OS), oxidative DNA damage, antioxidant enzymes, mitochondrial function, and mitophagy in SLE and LN. Although adaptive immunity’s participation in the development of autoimmunity is undeniable, increasing data emphasize the importance of innate immunity elements, particularly the Toll-like receptors (TLRs) that recognize nucleic acid ligands, in inflammatory and autoimmune diseases. Here, we discuss the intriguing roles of TLR7 and TLR9 in developing SLE and LN. Also included are the essential characteristics of conventional treatments and some other novel and little-explored alternatives that offer options to improve renal function in LN. Full article

(This article belongs to the Special Issue Oxidative Stress and Antioxidants in Human Diseases)

► Show Figures

Figure 1

24 pages, 2997 KiB

Open AccessReview

COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction

by Ekaterina Georgieva, Julian Ananiev, Yovcho Yovchev, Georgi Arabadzhiev, Hristo Abrashev, Despina Abrasheva, Vasil Atanasov, Rositsa Kostandieva, Mitko Mitev, Kamelia Petkova-Parlapanska, Yanka Karamalakova, Iliana Koleva-Korkelia, Vanya Tsoneva and Galina Nikolova

Int. J. Mol. Sci. 2023, 24(19), 14876; https://doi.org/10.3390/ijms241914876 - 04 Oct 2023

Cited by 11 | Viewed by 2285

Abstract

SARS-CoV-2 infection, discovered and isolated in Wuhan City, Hubei Province, China, causes acute atypical respiratory symptoms and has led to profound changes in our lives. COVID-19 is characterized by a wide range of complications, which include pulmonary embolism, thromboembolism and arterial clot formation, arrhythmias, cardiomyopathy, multiorgan failure, and more. The disease has caused a worldwide pandemic, and despite various measures such as social distancing, various preventive strategies, and therapeutic approaches, and the creation of vaccines, the novel coronavirus infection (COVID-19) still hides many mysteries for the scientific community. Oxidative stress has been suggested to play an essential role in the pathogenesis of COVID-19, and determining free radical levels in patients with coronavirus infection may provide an insight into disease severity. The generation of abnormal levels of oxidants under a COVID-19-induced cytokine storm causes the irreversible oxidation of a wide range of macromolecules and subsequent damage to cells, tissues, and organs. Clinical studies have shown that oxidative stress initiates endothelial damage, which increases the risk of complications in COVID-19 and post-COVID-19 or long-COVID-19 cases. This review describes the role of oxidative stress and free radicals in the mediation of COVID-19-induced mitochondrial and endothelial dysfunction. Full article

(This article belongs to the Special Issue Oxidative Stress and Antioxidants in Human Diseases)

► Show Figures

Figure 1

23 pages, 1377 KiB

Open AccessReview

Salivary Alterations of Myeloperoxidase in Patients with Systemic Diseases: A Systematic Review

by Kacper Nijakowski, Jakub Jankowski, Dawid Gruszczyński and Anna Surdacka

Int. J. Mol. Sci. 2023, 24(15), 12078; https://doi.org/10.3390/ijms241512078 - 28 Jul 2023

Cited by 3 | Viewed by 1330

Abstract

Salivary myeloperoxidase (MPO) is a key mediator of the oral immune system, acting as an enzyme that utilises H₂O₂ to generate molecules with high bactericidal activity. While MPO determination in plasma is quite common, the use of saliva is still rare. Our systematic review was designed to answer the question “Are salivary levels of myeloperoxidase altered in patients with systemic diseases?”. Following the inclusion and exclusion criteria, we included twenty-six studies. Altered MPO levels in saliva were most commonly found in patients with cardiovascular and gastrointestinal diseases. Most studies concerned unstimulated whole saliva, and only a few of them stimulated, mainly by chewing paraffin. Enzyme-linked immunosorbent assay (ELISA) was the most common method for determination of MPO concentrations in saliva. Increased salivary MPO levels were more often observed for inflammatory diseases, except patients with inflammatory bowel diseases who were eligible for biologic therapy. In conclusion, MPO could be altered in the saliva of patients with systematic diseases, especially cardiovascular or gastrointestinal diseases. However, further investigations are recommended to validate these outcomes. Full article

(This article belongs to the Special Issue Oxidative Stress and Antioxidants in Human Diseases)

► Show Figures